4D MOLECULAR THERAPEUTICS 35104E100 06/17/2026 Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES ISSUER 507801 0 FOR 507801 FOR AMYLYX PHARMACEUTICALS INC. 03237H101 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 151067 0 FOR 151067 FOR COMPASS THERAPEUTICS INC 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 851751 0 FOR 851751 FOR COMPASS THERAPEUTICS INC 20454B104 06/10/2026 To approve, on a non-binding, advisory basis, the holding of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 851751 0 1 YEAR 851751 FOR IDEAYA BIOSCIENCES INC. 45166A102 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 34844 0 FOR 34844 FOR JAZZ PHARMACEUTICALS PLC G50871105 07/24/2025 To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 4295 0 FOR 4295 FOR MINERVA NEUROSCIENCES INC. 603380205 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 709500 0 FOR 709500 FOR MINERVA NEUROSCIENCES INC. 603380205 06/03/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 709500 0 1 YEAR 709500 FOR MOONLAKE IMMUNOTHERAPEUTICS 03237H101 06/04/2026 Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 192364 0 FOR 192364 FOR OCULAR THERAPEUTIX 67576A100 06/10/2026 To approve an advisory vote on named executive officer compensation: Pravin U. Dugel, Merilee Raines SECTION 14A SAY-ON-PAY VOTES ISSUER 593976 0 FOR 593976 FOR OCULAR THERAPEUTIX 67576A100 06/10/2026 To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 593976 0 1 YEAR 593976 FOR PRAXIS PRECISION MEDICINES I 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES ISSUER 85168 0 FOR 85168 FOR REVOLUTION MEDICINES 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 13916 0 FOR 13916 FOR SURROZEN INC. 86889P208 05/13/2026 Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 172847 0 FOR 172847 FOR SURROZEN INC. 86889P208 05/13/2026 Advisory vote on the preferred frequency of the advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 172847 0 1 YEAR 172847 FOR SUTRO BIOPHARMA INC. 869367201 06/05/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 270251 0 FOR 270251 FOR TANGO THERAPEUTICS INC. 87583X109 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 443221 0 FOR 443221 FOR TAYSHA GENE THERAPIES INC. 877619106 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 439464 0 FOR 439464 FOR TAYSHA GENE THERAPIES INC. 877619106 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 439464 0 1 YEAR 439464 FOR UNITED THERAPEUTICS INC 91307C102 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 2224 0 FOR 2224 FOR VERASTEM INC. 92337C203 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 98550 0 FOR 98550 FOR ZYMEWORKS INC 98985Y108 12/30/2025 Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 80143 0 FOR 80143 FOR